Discovery of Potent 1,3-Cyclobutane-Containing Dual A2A/A2B Receptor Antagonists with Low Projected Human Dose for the Treatment of Cancer.
Brill ZG, Christian AH, Rico L, Schneider SE, Phillips EM, Winston MS, Krishnamurthy H, Hennessy ET, Mansoor UF, Xiao D, Su J, Liu P, Plummer C, Palmieri A, Vela Ramirez J, Hill A, Dewey W, Tatosian D, Rindgen D, Ogunbodede O, Smotrov N, Piesvaux J, Ciaccio P, Fan P, Afshar R, Daublain P, Presland J, Otte KM, Ali A, Cumming J, Ranganath S, DeMong D.
Brill ZG, et al. Among authors: su j.
ACS Med Chem Lett. 2026 Apr 14;17(5):1121-1131. doi: 10.1021/acsmedchemlett.6c00027. eCollection 2026 May 14.
ACS Med Chem Lett. 2026.
PMID: 42157841
Free PMC article.